NCT05864638 Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study
| NCT ID | NCT05864638 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Changhai Hospital |
| Condition | Acute Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-05-10 |
| Primary Completion | 2028-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-05-10 with a primary completion date of 2028-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A Multicenter Registry of Endovascular Treatment for Acute Ischemic Stroke.
Eligibility Criteria
Inclusion Criteria: 1. Acute ischemic stroke caused by anterior or posterior circulation vessel occlusion confirmed by computed tomography angiography (CTA) or magnetic resonance angiography (MRA) or digital subtraction angiography (DSA) 2. Undergo intravascular therapy (i.e. access to a cath lab and an arterial puncture) 3. The patient or his/her legal representative agreed to participate in the study and has signed the informed consent. Exclusion Criteria: 1\) No exclusion criteria
Contact & Investigator
Jianimin Liu, M.D.
PRINCIPAL INVESTIGATOR
Changhai Hospital
Frequently Asked Questions
Who can join the NCT05864638 clinical trial?
This trial is open to participants of all sexes, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05864638 currently recruiting?
Yes, NCT05864638 is actively recruiting participants. Contact the research team at 15921196312@163.com for enrollment information.
Where is the NCT05864638 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT05864638 clinical trial?
NCT05864638 is sponsored by Changhai Hospital. The principal investigator is Jianimin Liu, M.D. at Changhai Hospital. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.